In this week’s email to subscribers, independent trader and technical analyst Roberto Pedone commented on a few interesting small and micro-cap stocks. Below is a look at two micro-cap biopharmaceutical stocks that he likes.
Anthera Pharmaceuticals
Anthera Pharmaceuticals Inc ANTH is a Delaware-based biopharmaceutical company with a “nice looking ascending triangle chart setup” that looks ready to trigger over $5.10, to $5.25 and then beyond $5.33, Pedone says.
As it can be seen, the stock is “making higher lows over the last three months and now it's bouncing off both its 50-day at $4.54 and its 20-day at $4.69.”
The analyst assures he would only play this if gets really robust volume, “since it's tried to break out a few times recently and failed.” Support looks solid around $4.60.
Rock Creek Pharmaceuticals
Rock Creek Pharmaceuticals Inc RCPI is a $17.1 million market cap pharmaceutical company that, according to Pedone, has a chance of becoming the next Cleveland BioLabs, Inc. CBLI.
“Chart and share structure gives it a chance, so be on high alert for this one if it gets volume and starts ripping,” the analyst says.
“I'm not 100% sure if Yahoo Finance has the float right for $RCPI at 7.3 million, but nonetheless the chart is primed. Over $2.03 and then its 20-day at $2.17 could set it off, so look for massive volume like $CBLI had on Tuesday,” he adds, concluding that this is a thin name, and one should only take it if he/she is comfortable trading these.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.